270 related articles for article (PubMed ID: 35610002)
21. In Silico Identification of Anti-SARS-CoV-2 Medicinal Plants Using Cheminformatics and Machine Learning.
Liang J; Zheng Y; Tong X; Yang N; Dai S
Molecules; 2022 Dec; 28(1):. PubMed ID: 36615401
[TBL] [Abstract][Full Text] [Related]
22. Natural Products with Tandem Anti-inflammatory, Immunomodulatory and Anti-SARS-CoV/2 Effects: A Drug Discovery Perspective against SARS-CoV-2.
da Cunha LNOL; Tizziani T; Souza GB; Moreira MA; Neto JSS; Dos Santos CVD; de Carvalho MG; Dalmarco EM; Turqueti LB; Scotti MT; Scotti L; de Assis FF; Braga AL; Sandjo LP
Curr Med Chem; 2022; 29(14):2530-2564. PubMed ID: 34313197
[TBL] [Abstract][Full Text] [Related]
23. Discovery of Some Antiviral Natural Products to Fight Against Novel Coronavirus (SARS-CoV-2) Using an
Shah A; Patel V; Parmar B
Comb Chem High Throughput Screen; 2021; 24(8):1271-1280. PubMed ID: 32881661
[TBL] [Abstract][Full Text] [Related]
24. Natural Products as Potential Agents against SARS-CoV and SARSCoV- 2.
Raimundo E Silva JP; Acevedo CAH; de Souza TA; de Menezes RPB; Sessions ZL; Abreu LS; Cibulski SP; Scotti L; da Silva MS; Muratov EN; Scotti MT; Tavares JF
Curr Med Chem; 2021; 28(27):5498-5526. PubMed ID: 33550959
[TBL] [Abstract][Full Text] [Related]
25. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.
Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F
Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205
[TBL] [Abstract][Full Text] [Related]
26. Natural products for COVID-19 prevention and treatment regarding to previous coronavirus infections and novel studies.
Boozari M; Hosseinzadeh H
Phytother Res; 2021 Feb; 35(2):864-876. PubMed ID: 32985017
[TBL] [Abstract][Full Text] [Related]
27. Human coronaviruses and therapeutic drug discovery.
Song LG; Xie QX; Lao HL; Lv ZY
Infect Dis Poverty; 2021 Mar; 10(1):28. PubMed ID: 33726861
[TBL] [Abstract][Full Text] [Related]
28. An exhaustive comprehension of the role of herbal medicines in Pre- and Post-COVID manifestations.
Prajapati SK; Malaiya A; Mishra G; Jain D; Kesharwani P; Mody N; Ahmadi A; Paliwal R; Jain A
J Ethnopharmacol; 2022 Oct; 296():115420. PubMed ID: 35654349
[TBL] [Abstract][Full Text] [Related]
29. Target-Specific Drug Discovery of Natural Products against SARS-CoV-2 Life Cycle and Cytokine Storm in COVID-19.
Lee M; Park J; Cho IH
Am J Chin Med; 2022; 50(4):927-959. PubMed ID: 35729089
[TBL] [Abstract][Full Text] [Related]
30. Targeting natural products against SARS-CoV-2.
Al-Harrasi A; Behl T; Upadhyay T; Chigurupati S; Bhatt S; Sehgal A; Bhatia S; Singh S; Sharma N; Vijayabalan S; Palanimuthu VR; Das S; Kaur R; Aleya L; Bungau S
Environ Sci Pollut Res Int; 2022 Jun; 29(28):42404-42432. PubMed ID: 35362883
[TBL] [Abstract][Full Text] [Related]
31. Chalcone-amide, a privileged backbone for the design and development of selective SARS-CoV/SARS-CoV-2 papain-like protease inhibitors.
Valipour M
Eur J Med Chem; 2022 Oct; 240():114572. PubMed ID: 35797899
[TBL] [Abstract][Full Text] [Related]
32. An integrated method for optimized identification of effective natural inhibitors against SARS-CoV-2 3CLpro.
Liao Q; Chen Z; Tao Y; Zhang B; Wu X; Yang L; Wang Q; Wang Z
Sci Rep; 2021 Nov; 11(1):22796. PubMed ID: 34815498
[TBL] [Abstract][Full Text] [Related]
33. Potential medicinal plants involved in inhibiting 3CL
Yang F; Jiang XL; Tariq A; Sadia S; Ahmed Z; Sardans J; Aleem M; Ullah R; Bussmann RW
J Integr Med; 2022 Nov; 20(6):488-496. PubMed ID: 35985974
[TBL] [Abstract][Full Text] [Related]
34. Promising traditional Indian medicinal plants for the management of novel Coronavirus disease: A systematic review.
Singh RS; Singh A; Kaur H; Batra G; Sarma P; Kaur H; Bhattacharyya A; Sharma AR; Kumar S; Upadhyay S; Tiwari V; Avti P; Prakash A; Medhi B
Phytother Res; 2021 Aug; 35(8):4456-4484. PubMed ID: 34132429
[TBL] [Abstract][Full Text] [Related]
35. Natural Products: A Rich Source of Antiviral Drug Lead Candidates for the Management of COVID-19.
Wijayasinghe YS; Bhansali P; Viola RE; Kamal MA; Poddar NK
Curr Pharm Des; 2021; 27(33):3526-3550. PubMed ID: 33213322
[TBL] [Abstract][Full Text] [Related]
36. In a search for potential drug candidates for combating COVID-19: computational study revealed salvianolic acid B as a potential therapeutic targeting 3CLpro and spike proteins.
Elmaaty AA; Darwish KM; Khattab M; Elhady SS; Salah M; Hamed MIA; Al-Karmalawy AA; Saleh MM
J Biomol Struct Dyn; 2022; 40(19):8866-8893. PubMed ID: 33928870
[TBL] [Abstract][Full Text] [Related]
37. Herbal Medicines as Potential Inhibitors of SARS-CoV-2 Infection.
Rostami S; Gharibi S; Yaghoobi H; Nokhodian Z; Shoaei P; Bahrami AA; Ahangarzadeh S; Alibakhshi A
Curr Pharm Des; 2022; 28(29):2375-2386. PubMed ID: 35927924
[TBL] [Abstract][Full Text] [Related]
38. Natural Products and Nutrients against Different Viral Diseases: Prospects in Prevention and Treatment of SARS-CoV-2.
Ali SG; Ansari MA; Alzohairy MA; Almatroudi A; Alomary MN; Alghamdi S; Rehman S; Khan HM
Medicina (Kaunas); 2021 Feb; 57(2):. PubMed ID: 33673004
[TBL] [Abstract][Full Text] [Related]
39. Recent advances towards natural plants as potential inhibitors of SARS-Cov-2 targets.
He Z; Yuan J; Zhang Y; Li R; Mo M; Wang Y; Ti H
Pharm Biol; 2023 Dec; 61(1):1186-1210. PubMed ID: 37605622
[TBL] [Abstract][Full Text] [Related]
40. Synthetic and computational efforts towards the development of peptidomimetics and small-molecule SARS-CoV 3CLpro inhibitors.
Paul A; Sarkar A; Saha S; Maji A; Janah P; Kumar Maity T
Bioorg Med Chem; 2021 Sep; 46():116301. PubMed ID: 34332853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
